临床药师参与COVID-19患儿抗病毒治疗的药学监护

Pharmaceutical Care Practice of Clinical Pharmacist Participating in Antiviral Therapy for Children with COVID-19

目的通过参与新型冠状病毒肺炎(COVID-19)患儿的药物治疗实践,探讨临床药师参与COVID-19患儿的治疗和开展药学监护的方法。方法临床药师运用药学专业知识和最新的临床研究证据,参与和协助临床调整治疗方案,并对患儿家属进行用药教育。结果临床药师积极参与COVID-19患儿治疗过程的药学监护,及时发现患儿的药物治疗问题,提出合理化建议,并取得明显成效。结论临床药师参与COVID-19患儿药物治疗方案的制订,找到了融入临床治疗团队的切入点,将理论知识和临床实践相结合,优化药物治疗方案,既可提高临床药物治疗水平,又能提高患儿用药的安全性、有效性。

OBJECTIVE To explore the method of clinical pharmacists involved in the treatment of children with COVID-19 and pharmaceutical care, through the practice of drug treatment in children with COVID-19. METHODS The clinical pharmacists used the professional knowledge of pharmacy and the latest clinical research evidence to participate into the pharmaceutical care for one child with COVID-19, participated and assisted the clinic to adjust the treatment regimen, and administered education to the family members of the child. RESULTS Clinical pharmacist actively participated in the pharmacy care of child with COVID-19, timely detection of problems of drug use and could promote rational drug use in the clinic to achieve obvious results. CONCLUSION Clinical pharmacist participated in the formulation of drug treatment plan for child with COVID-19, and find an entry point into the clinical treatment team. Combining the theoretical knowledge and clinical practice can not only optimize the medication regimen and improve the level of clinical drug treatment, but also improve children’s medication safety and effectiveness.